Subcutaneously infused losartan for 2 weeks produced the same small hypotensive effect as centrally infused losartan, suggesting that the central AT1R contribution to BP is not evident in BPH/2 mice. This evidence concerns the gene AGTR1 and benign prostatic hyperplasia.